AHA: American Heart Association
Conference Coverage
EHR-based thromboembolism risk tool boosted prophylaxis
A thromboembolism risk calculator in a hospital’s EHR led to a significant rise in appropriate thromboprophylaxis and a drop in thromboembolic...
Conference Coverage
Dietary supplements hyped as LDL cholesterol lowering are a bust: SPORT
The list of supplements without effects on LDL in the placebo-controlled trial include commercial preparations of fish oil, cinnamon, garlic,...
From the Journals
‘Lucid dying’: EEG backs near-death experience during CPR
“Recalled experiences and brain wave changes may be the first signs of the so-called near-death experience.”
Conference Coverage
New trial suggests CV benefit with EPA: RESPECT-EPA
The open-label trial could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose...
Conference Coverage
Chinese herbal medicine may offer benefits in STEMI: CTS-AMI
Treatment with tongxinluo was tied to better outcomes out to 1 year, but observers say further data are needed to see how it may fit into STEMI...
Conference Coverage
Precision CAD testing shows 70% cut in composite risk at 1 year
A streamlined protocol for evaluating suspected stable chest pain substantially improved outcomes at 1 year in the PRECISE trial.
Conference Coverage
Avoid routine early ECMO in severe cardiogenic shock: ECMO-CS
Early ECMO in this setting is increasingly common, but it didn’t seem to improve outcomes in the trial, compared with a more conservative approach...
Conference Coverage
ISCHEMIA-EXTEND: Conservative stable CAD management holds up
The ISCHEMIA trial results showed equipoise between conservative and invasive management of stable CAD. Extended follow-up strengthened the...
Conference Coverage
CRISPR gene editing takes next step in TTR amyloidosis
A phase 1 study showed robust responses in patients with TTR amyloidosis with cardiomyopathy, similar to those reported last year in amyloid...
Conference Coverage
No survival advantage for either torsemide or furosemide in HF: TRANSFORM-HF
One loop diuretic is the most widely used in heart failure, the other may have advantages in some situations, but there’s been no head-to-head...
Conference Coverage
Acute heart failure risk assessment in ED improves outcomes: COACH
Systematic risk assessment of patients with acute heart failure in the ED significantly cut their 30-day and 20-month cardiovascular...
Conference Coverage
In CABG, radial artery works best for second key graft: RAPCO at 15 years
With more than 15 years of follow-up, the radial artery beats other options for the second key coronary target in coronary artery bypass surgery...
Conference Coverage
Puzzling, unique ECG from pig-to-human transplanted heart
The postimplantation electrocardiogram from the first pig heart xenotransplantation resembled neither a pig nor a human ECG, with unknown...
Conference Coverage
Diuretic agents equal to prevent CV events in hypertension: DCP
Cardiovascular events were nearly identical with two different hypertension drugs in the randomized Diuretic Comparison Project trial.
Conference Coverage
Triglyceride-lowering fails to show CV benefit in large fibrate trial
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on...